Skip to main content

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Pons Prata, Judit

Pons Prata, Judit

Shock, Organ Dysfunction and Resuscitation
Read more
Alarcon Gimenez, Irene

Alarcon Gimenez, Irene

Clinical Neuroimmunology
Read more
Solé Fernandez, Mireia

Solé Fernandez, Mireia

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Granda Soto, Alejandro

Granda Soto, Alejandro

Administration and Management
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.